private securities litigation
Entity, reached from Hormuz.
- Evidence
- 79 documents · 9 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 4 Sept 2026, last seen 8 Oct 2026
- Measured
- 48% of mentions say something specific about it; the rest only name it
- As of
- 8 Oct 2026
Where this comes from
- PR Newswire · 2026-10-08 · Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies (opens the source in a new tab)
- Financial Post · 2026-10-08 · TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 (opens the source in a new tab)
- Latest News · 2026-10-08 · Physician Research Points to a New Frontier for Stemtech Corporation: Nutritional Activation of the Body's Endogenous Regenerative System | STEK Stock News (opens the source in a new tab)
- PR Newswire · 2026-10-08 · Eminence Grey and Lumen Partner to Deliver Sovereign AI Infrastructure Across the U.S. (opens the source in a new tab)
- itweb.co.za · 2026-10-07 · New Global Survey Finds Majority of VMware Users Are Choosing Alternative Paths for Cost Control, Roadmap Flexibility and Better Support (opens the source in a new tab)
- IBM · 2026-10-07 · IBM and Red Hat Remediate More Than 400 Previously Unknown Open Source Vulnerabilities (opens the source in a new tab)
- PR Newswire · 2026-10-07 · FibroBiologics Files Patent Application for Technology Designed to Produce GLP-1 and Other Therapeutic Peptides Inside the Body (opens the source in a new tab)
- PR Newswire · 2026-10-07 · AbbVie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations From the U.S. FDA for CRC and NSCLC (opens the source in a new tab)
- PR Newswire · 2026-10-06 · TORM plc announces pricing of secondary public offering of its class A common shares (opens the source in a new tab)
- PR Newswire · 2026-10-06 · DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs (opens the source in a new tab)
2 more on file, counted in the evidence above.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with reform act (79 documents)seen together
- co-mentioned with forward-looking statements (75 documents)seen together
- co-mentioned with sec (63 documents)seen together
- co-mentioned with prnewswire (59 documents)seen together
- co-mentioned with exchange commission (51 documents)seen together
- co-mentioned with nasdaq (41 documents)seen together
- co-mentioned with risk factors (40 documents)seen together
- co-mentioned with u.s. securities (31 documents)seen together
- co-mentioned with nyse (27 documents)seen together
- co-mentioned with united states (27 documents)seen together